Prediction of In Vivo Interaction Between Triazolam and Erythromycin Based on In Vitro Studies Using Human Liver Microsomes and Recombinant Human CYP3A4

被引：0
|
作者：
Shin-ichi Kanamitsu
Kiyomi Ito
Carol E. Green
Charles A. Tyson
Noriaki Shimada
Yuichi Sugiyama
机构：
[1] University of Tokyo,Graduate School of Pharmaceutical Sciences
[2] Kitasato University,School of Pharmaceutical Sciences
[3] SRI International,Toxicology Laboratory
[4] Daiichi Pure Chemicals Co.,Research and Development Division
[5] LTD.,Graduate School of Pharmaceutical Sciences
[6] University of Tokyo,undefined
来源：
Pharmaceutical Research | 2000年 / 17卷
关键词：
drug interaction; mechanism-based inhibition; triazolam; erythromycin; physiologically-based pharmacokinetics;
D O I：
暂无
中图分类号：
学科分类号：
摘要：
Purpose. To quantitatively predict the in vivo interaction betweentriazolam and erythromycin, which involves mechanism-basedinhibition of CYP3A4, from in vitro studies using human liver microsomes(HLM) and recombinant human CYP3A4 (REC).
引用
收藏
页码：419 / 426
页数：7
相关论文
共 50 条
  • [41] Different effects of dihydropyridine calcium channel antagonists on CYP3A4 enzyme of human liver microsomes
    Xia, Zongling
    Wang, Mingli
    Zou, Sulan
    Chen, Rong
    EUROPEAN JOURNAL OF DRUG METABOLISM AND PHARMACOKINETICS, 2012, 37 (03) : 211 - 216
  • [42] Different effects of dihydropyridine calcium channel antagonists on CYP3A4 enzyme of human liver microsomes
    Zongling Xia
    Mingli Wang
    Sulan Zou
    Rong Chen
    European Journal of Drug Metabolism and Pharmacokinetics, 2012, 37 : 211 - 216
  • [43] Effect of recombinant CYP3A4 variants and interaction on imatinib metabolism in vitro
    Chen, Jie
    Hu, Yingying
    Hu, Jinyu
    Ye, Zhize
    Lin, Qianmeng
    Cai, Jian-ping
    Hu, Guo-xin
    Xu, Ren-ai
    BIOMEDICINE & PHARMACOTHERAPY, 2024, 180
  • [44] A study of the in vitro interaction between lidocaine and premedications using human liver microsomes
    Nagashima, A
    Tanaka, E
    Inomata, S
    Honda, K
    Misawa, S
    JOURNAL OF CLINICAL PHARMACY AND THERAPEUTICS, 2005, 30 (02) : 185 - 188
  • [45] CYP3A4 is mainly responsibile for the metabolism of a new vinca alkaloid, vinorelbine, in human liver microsomes
    Kajita, J
    Kuwabara, T
    Kobayashi, H
    Kobayashi, S
    DRUG METABOLISM AND DISPOSITION, 2000, 28 (09) : 1121 - 1127
  • [46] In-Vitro CYP3A4, CYP2E1 and UGT Activity in Human Liver Microsomes by Strobilanthes crispus Leaf Extracts
    Akowuah, Gabriel Akyirem
    Chin, Jin Han
    Yeong, Siew Wei
    Quah, Suk Yen
    Ahmad, Mariam
    NATURAL PRODUCTS JOURNAL, 2020, 10 (02): : 104 - 112
  • [47] Metabolism of endosulfan-α by human liver microsomes and its utility as a simultaneous in vitro probe for CYP2B6 and CYP3A4
    Casabar, Richard C. T.
    Wallace, Andrew D.
    Hodgson, Ernest
    Rose, Randy L.
    DRUG METABOLISM AND DISPOSITION, 2006, 34 (10) : 1779 - 1785
  • [48] Prediction of clinical CYP3A4 induction using cryopreserved human hepatocytes
    Kaneko, A.
    Kato, M.
    Endo, C.
    Nakano, K.
    Ishigai, M.
    Takeda, K.
    XENOBIOTICA, 2010, 40 (12) : 791 - 799
  • [49] Role of CYP2B6 and CYP3A4 in the in vitro N-dechloroethylation of (R)- and (S)-ifosfamide in human liver microsomes
    Granvil, CP
    Madan, A
    Sharkawi, M
    Parkinson, A
    Wainer, IW
    DRUG METABOLISM AND DISPOSITION, 1999, 27 (04) : 533 - 541
  • [50] Selective degradation of CYP3A4 in human liver microsome
    Sasaki, Yu
    Hisaka, Akihiro
    Suzuki, Hiroshi
    DRUG METABOLISM REVIEWS, 2011, 43 : 45 - 46
12345